BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 4247030)

  • 21. Fibrinolytic inhibitors in human seminal plasma.
    Liedholm P; Astedt B
    Experientia; 1974 Oct; 30(10):1113-4. PubMed ID: 4279828
    [No Abstract]   [Full Text] [Related]  

  • 22. Determination of fast-acting plasmin inhibitor (alpha2-antiplasmin) in plasma from patients with tendency to thrombosis and increased fibrinolysis.
    Teger-Nilsson AC; Gyzander E; Myrwold H; Noppa H; Olsson R; Wallmo L
    Haemostasis; 1978; 7(2-3):155-7. PubMed ID: 149047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Biochemistry of fibrinolysis].
    Schwick HG
    Thromb Diath Haemorrh Suppl; 1967; 22():27-46. PubMed ID: 4231070
    [No Abstract]   [Full Text] [Related]  

  • 24. Possibilities of development of fibrinolytic activity with new and projected agents.
    Cliffton EE
    Angiologica; 1968; 5(2):146-60. PubMed ID: 4232515
    [No Abstract]   [Full Text] [Related]  

  • 25. Plasma protease and kinin release with special reference to plasmin.
    Hamberg U
    Ann N Y Acad Sci; 1968 Jun; 146(2):517-26. PubMed ID: 4240400
    [No Abstract]   [Full Text] [Related]  

  • 26. [Thrombolytic therapy. I. Introduction and principles of therapy. Indications. Contraindications. Schematics of the treatment].
    Sterkowicz S
    Przegl Lek; 1969; 25(8):565-8. PubMed ID: 4897431
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immunologic evidence of products of fibrinolysis in the course of thrombolytic treatment].
    Mazák J; Matĕja F
    Vnitr Lek; 1971 Aug; 17(8):782-7. PubMed ID: 4998902
    [No Abstract]   [Full Text] [Related]  

  • 28. [Blood fibrinolytic system in patients with ischemic heart disease].
    Liusov VA; Belousov IuB; Torchinskaia LE; Kozlova LS; To-Nam-Zen
    Kardiologiia; 1973; 13(6):12-6. PubMed ID: 4269162
    [No Abstract]   [Full Text] [Related]  

  • 29. [Current situation and developmental trends in the field of thrombolytic agents].
    Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(1):5-8. PubMed ID: 4134480
    [No Abstract]   [Full Text] [Related]  

  • 30. [Contemporary data on the human fibrinolytic system].
    Andreenko GV
    Klin Med (Mosk); 1970 Oct; 48(10):16-24. PubMed ID: 4252327
    [No Abstract]   [Full Text] [Related]  

  • 31. [Natural inhibitors of fibrinolysis and thrombohemorrhagic phenomena].
    Moriau M
    Pathol Eur; 1969; 4():Suppl 1:9-286. PubMed ID: 4244510
    [No Abstract]   [Full Text] [Related]  

  • 32. [Disorders in blood coagulation and in mucopolysaccharides in patients with myocardial infarction and angina pectoris before and after heparin loading].
    Olszewski W
    Pol Tyg Lek; 1968 Dec; 23(51):1963-6. PubMed ID: 4236501
    [No Abstract]   [Full Text] [Related]  

  • 33. Experimental thrombolysis by perfusion. II. Comparative study on the effect of streptokinase, urokinase and plasmin.
    Egeblad K; Bertelsen S
    Acta Chir Scand; 1969; 135(6):486-90. PubMed ID: 4244115
    [No Abstract]   [Full Text] [Related]  

  • 34. Sequential treatment of deep leg vein thrombosis with porcine plasmin and low dose streptokinase.
    Marbet GA; Eichlisberger R; Duckert F; de Silva MA; Biland L; Widmer LK; Ritz R; Schmitt HE
    Thromb Haemost; 1982 Oct; 48(2):190-5. PubMed ID: 6217581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in the coagulation and fibrinolytic systems predisposing to thrombosis.
    Nilsson IM
    Acta Chir Scand Suppl; 1968; 387():15-22. PubMed ID: 4240349
    [No Abstract]   [Full Text] [Related]  

  • 36. Plasmin, plasmin inhibitors, and degradation products of fibrinogen in human serum during and after intravenous infusion of streptokinase.
    Nilsson IM
    J Clin Pathol; 1969 May; 22(3):371. PubMed ID: 4239466
    [No Abstract]   [Full Text] [Related]  

  • 37. An immunochemical study of human plasminogen and plasmin.
    Robbins KC; Summaria L
    Immunochemistry; 1966 Jan; 3(1):29-40. PubMed ID: 4223674
    [No Abstract]   [Full Text] [Related]  

  • 38. [The status of the blood anticoagulation system in angina pectoris and myocardial infarct].
    Maĭorov IuM
    Kardiologiia; 1968 Jan; 8(1):24-30. PubMed ID: 5654236
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pathogenesis, prophylaxis and therapy of hemostatic disorders in congenital cardiopathies].
    Perlick E; Ursinus K; Ursinus W; Hofmann G
    Z Gesamte Inn Med; 1971 Sep; 26(17):545-51. PubMed ID: 5125158
    [No Abstract]   [Full Text] [Related]  

  • 40. The preparation and evaluation of a standardized fibrin plate for the assessment of fibrinolytic activity.
    Bishop R; Ekert H; Gilchrist G; Shanbrom E; Fekete L
    Thromb Diath Haemorrh; 1970 May; 23(2):202-10. PubMed ID: 4246603
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.